Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

PDC*line Pharma enters into a licensing agreement with leading Korean pharmaceutical company LG Chem to develop PDC*lung cancer vaccine in Asia

firstwordpharmaMarch 21, 2019

Tag: PDC*line Pharma , licensing agreement , lung cancer vaccine

PharmaSources Customer Service